Federal Register / Vol. 79, No. 210 / Thursday, October 30, 2014 / Notices 64605 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2009–N–0383] 

Request for Nominations on the 

Tobacco Products Scientific Advisory 

Committee 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is requesting that 

any small business tobacco 

manufacturing industry organizations 

interested in participating in the 

selection of nonvoting industry 

representatives to represent the interests 

of the small business tobacco 

manufacturing industry, to serve on the 

Tobacco Products Scientific Advisory 

Committee for the Center for Tobacco 

Products notify FDA in writing. FDA is 

also requesting nominations for 

nonvoting industry representatives to be 

included in a pool of individuals to 

represent the interests of the small 

business tobacco manufacturing 

industry on the Tobacco Products 

Scientific Advisory Committee. A 

nominee may either be self-nominated 

or nominated by an organization to 

serve as a nonvoting industry 

representative. This position may be 

filled on a rotating, sequential basis by 

representatives of different small 

business tobacco manufacturers based 

on areas of expertise relevant to the 

topics being considered by the Advisory 

Committee. Nominations will be 

accepted for current vacancies effective 

with this notice. 

DATES: Any small business tobacco 

manufacturing industry organization 

interested in participating in the 

selection of an appropriate nonvoting 

member to represent the interests of the 

small business tobacco manufacturing 

industry, must send a letter stating that 

interest to FDA by December 1, 2014 

(see sections I and II of this document 

for details). Concurrently, nomination 

materials for prospective candidates 

should be sent to FDA by December 1, 

2014. 

ADDRESSES: All statements of interest 

from small business tobacco 

manufacturing industry organizations 

interested in participating in the 

selection process of nonvoting industry 

representative nominations should be 

sent to Caryn Cohen (see FOR FURTHER

INFORMATION CONTACT). All nominations 

for nonvoting industry representatives 

may be submitted electronically by 

accessing the FDA Advisory Committee 

Membership Nomination Portal: https:// 

www.accessdata.fda.gov/scripts/

FACTRSPortal/FACTRS/index.cfm or by 

mail to Advisory Committee Oversight 

and Management Staff, Food and Drug 

Administration, 10903 New Hampshire 

Ave., Bldg. 32, rm. 5103, Silver Spring, 

MD 20993–0002. Information about 

becoming a member of an FDA advisory 

committee can also be obtained by 

visiting FDA’s Web site http://

www.fda.gov/AdvisoryCommittees/

default.htm. 

FOR FURTHER INFORMATION CONTACT: 

Caryn Cohen, Office of Science, Center 

for Tobacco Products, Food and Drug 

Administration, Center for Tobacco 

Products Document Control Center, 

Bldg. 71, rm. G335, 10903 New 

Hampshire Ave., Silver Spring, MD 

20993–0002,1–877–287–1373 (choose 

Option 5), FAX: 240–276–3655, 

TPSAC@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

Agency intends to add a nonvoting 

industry representative to represent the 

interests of the small business tobacco 

manufacturing industry, to the 

following advisory committee (this 

position may be filled on a rotating, 

sequential basis by representatives of 

different small business tobacco 

manufacturers based on areas of 

expertise relevant to the topics being 

considered by the Advisory Committee). 

I. Tobacco Products Scientific Advisory 

Committee 

The Tobacco Products Scientific 

Advisory Committee (the Committee) 

advises the Commissioner of Food and 

Drugs (the Commissioner) or designee in 

discharging responsibilities related to 

the regulation of tobacco products. The 

Committee reviews and evaluates safety, 

dependence, and health issues relating 

to tobacco products and provides 

appropriate advice, information, and 

recommendations to the Commissioner. 

The Committee includes three 

nonvoting members who represent 

industry interests. These members 

include one representative of the 

interests of the tobacco manufacturing 

industry, one representative of the 

interests of tobacco growers, and one 

representative of the interests of the 

small business tobacco manufacturing 

industry, which may be filled on a 

rotating, sequential basis by 

representatives of different small 

business tobacco manufacturers based 

on areas of expertise relevant to the 

topics being considered by the Advisory 

Committee. 

With this notice, nominations are 

sought for the following positions: A 

pool of individuals, with varying areas 

of expertise, to represent the interests of 

the small business tobacco 

manufacturing industry on a rotating, 

sequential basis. 

II. Selection Procedure 

Any small business tobacco 

manufacturing industry organization 

interested in participating in the 

selection of an appropriate nonvoting 

member to represent the interests of the 

small business tobacco manufacturing 

industry, must send a letter stating that 

interest to the FDA contact (see FOR

FURTHER INFORMATION CONTACT) within 

30 days of publication of this document 

(see DATES). Within the subsequent 30 

days, FDA will send a letter to each 

organization that has expressed an 

interest, attaching a complete list of all 

such organizations; and a list of all 

nominees along with their current 

re ́sume ́s. The letter will also state that 

it is the responsibility of the interested 

organizations to confer with one another 

and to select a candidate or candidates 

(to serve in a pool of individuals, with 

varying areas of expertise, to represent 

the interests of the small business 

tobacco manufacturing industry on a 

rotating, sequential basis), within 60 

days after the receipt of the FDA letter, 

to serve as the nonvoting member to 

represent industry interests for the 

committee. The interested organizations 

are not bound by the list of nominees in 

selecting a candidate or candidates. 

However, if no individual is selected 

within 60 days, the Commissioner will 

select the nonvoting member (or pool of 

individuals) to represent the small 

business tobacco manufacturing 

industry interests. 

III. Application Procedure 

Individuals may self nominate and/or 

an organization may nominate one or 

more individuals to serve as a nonvoting 

industry representative. Contact 

information, a current curriculum vitae, 

and the name of the committee of 

interest should be sent to the FDA 

contact person (see FOR FURTHER

INFORMATION CONTACT) within 30 days of 

publication of this document (see 

DATES). FDA will forward all 

nominations to the organizations 

expressing interest in participating in 

the selection process for the committee. 

(Persons who nominate themselves as 

nonvoting industry representatives will 

not participate in the selection process.) 

FDA seeks to include the views of 

women and men, members of all racial 

and ethnic groups, and individuals with 

and without disabilities on its advisory 

committees and, therefore encourages 

nominations of appropriately qualified 


tkelley on DSK3SPTVN1PROD with NOTICES
64606 Federal Register / Vol. 79, No. 210 / Thursday, October 30, 2014 / Notices 

candidates from these groups. This 

notice is issued under the Federal 

Advisory Committee Act (5 U.S.C. app. 

2) and 21 CFR part 14, relating to 

advisory committees. 

Dated: October 24, 2014. 

Leslie Kux, 

Assistant Commissioner for Policy. 

[FR Doc. 2014–25795 Filed 10–29–14; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Non-HIV Diagnostics, Food Safety, 

Sterilization/Disinfection and 

Bioremediation. 

Date: November 17–18, 2014. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road NW., 

Washington, DC 20015. 

Contact Person: Gagan Pandya, Ph.D., 

Scientific Review Officer, National Institutes 

of Health, Center for Scientific Review, 6701 

Rockledge Drive, RM 3200, MSC 7808, 

Bethesda, MD 20892, 301–435–1167, 

pandyaga@mai.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Vaccines 

Against Microbial Diseases—Special. 

Date: November 18–19, 2014. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Jian Wang, MD, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4198, 

MSC 7812, Bethesda, MD 20892, (301) 435– 

2778, wangjia@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Program 

Project: Structural bases of the functions of 

RNA-protein machines. 

Date: November 19–20, 2014. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Kathryn M Koeller, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4166, 

MSC 7806, Bethesda, MD 20892, 301–435– 

2681, koellerk@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Bioengineering Sciences and Technologies: 

AREA Review Group 2. 

Date: November 19–20, 2014. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Ping Fan, MD, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5154, 

MSC 7840, Bethesda, MD 20892, 301–408– 

9971, fanp@csr.nih.gov. 

Name of Committee: AIDS and Related 

Research Integrated Review Group; 

NeuroAIDS and other End-Organ Diseases 

Study Section. 

Date: November 20, 2014. 

Time: 8:00 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Fairmont Washington, DC, 2401 

M Street NW., Washington, DC 20037. 

Contact Person: Robert Freund, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Dr. Room 3216, 

Bethesda, MD 20892, 301–435–1050, 

freundr@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflicts: Asthma, COPD and Host Defense. 

Date: November 20–21, 2014. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Ghenima Dirami, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4122, 

MSC 7814, Bethesda, MD 20892, 240–498– 

7546, diramig@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Oncology 1 

Basic Translational—Member Conflicts. 

Date: November 20, 2014. 

Time: 9:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Manzoor Zarger, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6208, 

MSC 7804, Bethesda, MD 20892, (301) 435– 

2477, zargerma@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Training: 

Comparative Medicine. 

Date: November 20–21, 2014. 

Time: 11:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Sergei Ruvinov, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4158, 

MSC 7806, Bethesda, MD 20892, 301–435– 

1180, ruvinser@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Vascular Regulation and 

Hematology. 

Date: November 20–21, 2014. 

Time: 1:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Ai-Ping Zou, MD, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4118, 

MSC 7814, Bethesda, MD 20892, 301–408– 

9497, zouai@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR–14– 

011, Genomic Underpinnings of Response to 

Rehabilitation Interventions. 

Date: November 20, 2014. 

Time: 2:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Biao Tian, Ph.D., Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 3089B, MSC 7848, Bethesda, 

MD 20892, (301) 402–4411, 

tianbi@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: October 24, 2014. 

Anna Snouffer, 

Deputy Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2014–25761 Filed 10–29–14; 8:45 am] 

BILLING CODE 4140–01–P 


tkelley on DSK3SPTVN1PROD with NOTICES